ArticleActa pharmaceutica Sinica. B2021

Design, synthesis, and biological evaluation of Bcr-Abl PROTACs to overcome T315I mutation.

Liang Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.